SCHEMBL19964973

SCHEMBL19964973

CCOC(=O)c1cc2c(-c3ccnc(N(C)C)c3)ncn2c(N(CC)C2CCN(CC(F)(F)F)CC2)c1C

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 2/20 0.35
MAPK1 P28482 3/20 0.32
SYK P43405 1/20 0.32
GUCY1A1 Q02108 1/20 0.32
GUCY1B1 Q02153 1/20 0.32
EIF4EBP1 Q13541 1/20 0.31
PROKR1 Q8TCW9 3/20 0.31
EZH2 Q15910 1/20 0.30
GSK3B P49841 1/20 0.30
MAPK14 Q16539 1/20 0.30
PIK3CA P42336 1/20 0.30
MTOR P42345 1/20 0.30
KAT6A Q92794 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21113074 0.92 HPGDS (0.37) HPGDSMAPK1EIF4EBP1PROKR1EZH2
SCHEMBL19964715 0.89 EZH2 (0.37) HPGDSSYKGUCY1A1GUCY1B1EIF4EBP1
SCHEMBL19964972 0.87 GPR119 (0.43) EZH2
SCHEMBL21113163 0.86 EZH2 (0.35) SYKEZH2GSK3BMAPK14
SCHEMBL21157379 0.82 EZH2 (0.37) HPGDSGUCY1A1GUCY1B1EIF4EBP1PROKR1
SCHEMBL19964731 0.81 EZH2 (0.36) HPGDSEIF4EBP1PROKR1EZH2MTOR
SCHEMBL21113434 0.78 EZH2 (0.38) PROKR1EZH2
SCHEMBL21113349 0.76 JAK3 (0.38) SYK
SCHEMBL21113305 0.73 NOS2 (0.41) SYK
SCHEMBL21342285 0.73 EZH2 (0.41) HPGDSGUCY1A1GUCY1B1EZH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed
WO-2018045971-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海海和药物研究开发有限公司 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 HPGDS 2617/4885MAPK1 869/4885SYK 1054/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 HPGDS 2617/4885MAPK1 869/4885SYK 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.